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Abstract 
An elevated concentration of copper ions in the brain of Alzheimer's disease (AD) patients 
has been reported in many studies and might be associated with an increased aggregation of 
-amyloid (A) peptides. In the present work, the interaction with copper ions of a model -
amyloid peptide, A(1-16), was investigated by electrospray ionization-mass spectrometry 
(ESI-MS) at two pH values, 7.4 and 6.6, as well as at various peptide: copper ion ratios in the 
first minutes after components mixing and time intervals. Our results indicated that copper 
ions specifically bound to A(1-16) peptide in solution and that the complex formation 
increased with time. Once formed in solution, Cu
2+
-Aβ(1-16) complexes could easily be 
detected in the gas phase by ESI-MS. The pH shift from 7.4 to 6.6 only slightly influenced the 
Cu
2+ 
binding to A(1-16). No oligomerization of A(1-16) peptide was noticed in the first 
minutes of copper-peptide interaction. 
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Introduction 
There is increasing evidence that heavy metal ions are involved in the pathogenesis of 
neurodegenerative diseases, such as Alzheimer’s disease (AD).1-5 The aggregation of -
amyloid peptides (Aβ) and subsequent neurotoxicity may be triggered by abnormal 
interactions with neocortical metal ions, especially copper, zinc, iron and aluminum.
2,6
 Recent 
data suggest that the intracellular pool of Aβ is regulated by the activity of endothelin-
converting enzymes at the sites of production.
7
 However, the deregulation of copper seems to 
be intimately involved in the pathogenesis of AD.
8,9
 Copper is known to accelerate the 
aggregation of Aβ(1-40) and Aβ(1-42) peptides, the major components of Aβ deposits.10 
Nevertheless, short and easy-to-handle peptides have been used to study the structures and 
mechanisms that are also relevant for the native and longer peptides involved in 
neurodegenerative diseases.
11,12 
Moreover, some previous ESI-MS studies have reported on  
the binding of Cu
2+
 to Aβ(1–16) at physiological pH and its effect on peptide conformation 
and oligomerisation.
12 
The copper binding sites are located in the N-terminal region of Aβ 
peptides.
2,13-15
 Furthermore, the mode of copper binding to peptides seems to be highly pH 
dependent.
16-19
 The most common methods used to investigate the interaction of metal ions 
with amyloidogenic peptides have already been reviewed.
20,21
 Yet, it is less known if copper-
peptide complexes are formed in the gas phase as non-specific adducts or in solution.  
We explore here the hypothesis that under in-solution conditions (pH, time of reaction, 
metal and peptide concentrations) various species of copper-peptide complexes may result, 
which are mostly conserved in the gas phase and can be detected by ESI-MS. Thus, the 
present work aims at investigating the formation of complexes between Aβ(1-16) and copper 
ions in solution, both at pH 6.6 and pH 7.4.    
 
Experimental 
Materials. All reagents were of analytical grade or highest available purity. The 
solutions were prepared using MilliQ grade water (18 M·cm). The A(1-16) peptide (H-
DAEFRHDSGYEVHHQK-OH) was purchased from Bachem AG (Bubendorf, Switzerland). 
ESI-ion trap mass spectrometry. Electrospray ionization mass spectrometric analyses 
were carried out on a Bruker Daltonics Esquire 3000plus ion trap mass spectrometer (Bremen, 
Germany). Spectra were acquired in the 50-2000 m/z range. Binding of metal ions to A(1-
16) peptide was investigated by ESI-ion trap MS using 5 mM ammonium acetate, pH 7.4 or 
6.6 as a solvent. Peptide concentration was 10 M and the peptide: copper ion ratios were 1:1, 
1:2 and 1:10. A(1-16) and CuSO4 were first dissolved in 5 mM ammonium acetate and 
mixed prior to MS analysis. Copper binding to Aβ(1-16) peptide was followed over time, in 
the first minutes after mixing, while recording the mass spectra (no preincubation of the 
samples was performed). The experiments were carried out either under nearly physiological 
conditions (5 mM salt concentration, pH 7.4) or at pH 6.6, representing the pH value 
determined in the case of inflammatory processes. 
Circular dichroism (CD) spectroscopy. CD spectra were recorded on a Jasco J-715 
spectropolarimeter at room temperature, in quartz cells of 0.05 cm path length, under constant 
nitrogen flush. The Aβ(1-16) peptide was dissolved in 5 mM ammonium acetate, at a 
concentration of 0.2 mM, while the molar ratio Cu
2+: Aβ(1-16) was 2:1. The spectra were 
recorded after preincubating the samples for 1 min and 7 min, respectively; the spectra were 
averages of six scans in the wavelength range 180 - 260 nm. Molar ellipticity was expressed 
as deg cm
2
 dmol
-1
.  
 
Results 
Copper binding to Aβ(1-16) peptide. Using ESI-MS, we found that the binding of Cu2+ 
to A(1-16) peptide was significantly influenced by the molar ratio of peptide: copper ion and 
the time of peptide-metal ion contact, being only slightly influenced by the pH. However, 
more copper was bound to A(1-16) at pH 6.6 than at pH 7.4, although the complex 
formation was faster at pH 7.4. A(1-16) peptide, at a concentration of 10 µM in 5 mM 
ammonium acetate, pH 7.4,  displayed a peak in the ESI-mass spectrum at m/z 652.6 and 
another one at m/z 978.5 that were assigned to [M+3H]
3+
 and [M+2H]
2+
 ions (Fig. 1a). Under 
the same experimental conditions and upon adding Cu
2+
, the intensity of the peptide peak 
decreased to 26.8% in the first 0.1-0.5 min after mixing the peptide with the copper ions. The 
average mass spectrum between 7.3 and 7.6 min showed a further decrease in the intensity of 
the peptide peak (15.3%), whereas that of [M+Cu+H]
3+
 ion was found to be 220.7% higher 
than that of the peptide (Fig. 1c). Copper ions demonstrated a high affinity toward A(1-16), 
since [M+Cu+H]
3+
 ion appeared immediately after mixing the two components and its 
intensity was high enough (96.1% of peptide intensity). The formation of copper-peptide 
complex was also observed at m/z 1009.4, the peak being assigned to [M+Cu]
2+
 ion.  
A(1-16) peptide bound only one Cu2+ at both pH 7.4 and 6.6, at a molar ratio of 1:1 
peptide: Cu
2+
. At pH 6.6, for the time interval 0.2-0.7 min from mixing the components (Fig. 
2a), the [M+Cu+H]
3+
: [M+3H]
3+
 intensity ratio was found to be lower than that at pH 7.4 
(57.1% vs 96.1%). However, while the intensity of the peak corresponding to [M+Cu+H]
3+
 
ion was rather the same (6·104 at pH 6.6 vs 4.9·104 at pH 7.4), that of the peptide ion was 
much higher (10.5·104 at pH 6.6 vs 5.1·104 at pH 7.4), most probably due to the higher proton 
concentration of the solution and better ionization of the peptide under slightly acidic 
conditions. Over time (7.9-8.1 min, pH 6.6), the intensity of [M+Cu+H]
3+ 
ion doubled, while 
that of the peptide ion decreased three times (Fig. 2b). When compared with the results 
obtained at pH 7.4, both the [M+Cu+H]
3+
 intensity and the [M+Cu+H]
3+
: [M+3H]
3+
 intensity 
ratio were found to be higher (12.0·104 vs 6.4·104; 3.43 vs 2.66). 
When copper: A(1-16) ratio increased up to 10, the intensity of the peaks 
corresponding to the triply charged ions, [M+Cu+H]
3+
,
 
suddenly increased as well; no trace of 
peptide ion was found at pH 7.4, while a low intensity peak was observed at m/z 652.7, being 
assigned to [M+3H]
3+
 molecular ion. At pH 6.6 and about 0.5 min reaction time, the 
[M+3H]
3+ 
: [M+Cu+H]
3+ 
: [M+2Cu-H]
3+
 intensity ratio was 1: 8.9: 2.8. In only eight minutes, 
[M+3H]
3+
 ion completely disappeared, [M+Cu+H]
3+
 decreased dramatically, while [M+2Cu-
H]
3+
 became the main peak in the mass spectrum (Fig. 2d). Both at pH 7.4 and pH 6.6, the 
[M+2Cu-H]
3+
 ion peak had the same intensity. Interestingly, [M+Cu+H]
3+
 ion displayed at 
m/z 673.3 and pH 7.4 a peak as intense as that characteristic for the [M+3Cu-3H]
3+
 ion at pH 
6.6. Hence, more copper was bound to A(1-16) at pH 6.6 than at pH 7.4, although the 
complex formation was faster at pH 7.4.  
Copper binding stoichiometry. ESI-MS showed binding stoichiometries of up to 1:3 
(pH 7.4) and 1:4 (pH 6.6) for the peptide-Cu
2+
 complexes, when Cu
2+
: peptide molar ratio 
was 10:1 (Fig. 3). We assumed that in spite of the elevation of both peptide and copper ion 
concentrations during the ionization process than in the incubation buffer, the ratio between 
the copper ion and Aβ(1-16) would be fixed even after evaporation of the solvent as shown by 
other studies.
12,22
 Moreover, since there is an increase in the copper content of Cu
2+
-Aβ(1-16) 
complexes from fractions with higher copper to peptide ratios, this would suggest that the 
metal was attached to the peptide prior to ESI-MS analysis. We demonstrate here that Aβ(1-
16) is able to bind up to three Cu
2+
 ions at pH 7.4, and up to four Cu
2+
 ions when the pH value 
decreased to 6.6.  
CD spectroscopy. The CD spectra presented in Fig. 4 indicated that the binding of 
copper ions to Aβ(1-16) could significantly influence the peptide conformation. The far UV 
CD spectrum of an aqueous solution of Aβ(1-16) (0.2 mM concentration) was characterized 
by two negative maxima at 191 nm and 198 nm, and other two positive ones at 183 nm and 
220 nm, indicating predominant random coil conformation. In the first minute of copper 
interaction with Aβ(1-16), when a relatively small proportion of metal ions was bound to the 
peptide, a slight conformational change of the peptide was observed. The spectral features 
were comparable to those of the peptide in the absence of copper ions; however, the bands at 
183 and 191 nm had increased intensity, while the negative maximum at 198 nm shifted to 
196.5 nm. Moreover, the positive band at 200 nm decreased to negative values and shifted to 
203 nm. Over time (7-8 min), more copper bound to Aβ(1-16), resulting in a completely 
different CD spectrum of the peptide, in which only its ellipticity in the range from 200 nm to 
260 nm was similar to that for the spectrum recorded at about 1 min from mixing. Two 
negative maxima at 199.5 nm (69.1% of the negative ellipticity of peptide at 198 nm) and 
194.5 nm (73.7%) were the main changes in the spectrum, while the positive maximum at 183 
nm shifted to 186 nm and had decreased ellipticity. The CD spectrum after 7 min may 
indicate the presence of a mixture of conformers. 
These data clearly indicate that copper ions bind to Aβ(1-16) over time in solution and 
not in the gas phase. Nevertheless, the possibility of forming non specific adducts in the gas 
phase was not excluded. 
Time- and pH dependences of copper binding.  The time-dependent formation of species 
of Aβ(1-16):Cu2+ complex was followed by mass spectrometry at pH 6.6 and 1:10 peptide: 
copper molar ratio (Fig. 5), and at pH 7.4 and 1:1 peptide: copper molar ratio (Fig. 6). At high 
copper: peptide molar ratio, the free peptide almost disappeared in the first 2 minutes, while 
the intensity of 1:1 Cu
2+:Aβ(1-16) species increased dramatically in the first minute after 
mixing to decrease quickly in the second one. Once formed, the 1:1 Cu
2+:Aβ(1-16) complex 
did bind the second copper ion to form the 2:1 Cu
2+:Aβ(1-16) complex, whose intensity also 
increased for the time interval from minute 1 to minute 2, and remained almost constant up to 
minute 6. The 3:1 Cu
2+:Aβ(1-16) complex showed an increasing intensity for 1.5 min after 
mixing the solutions, followed by a rather unchanged intensity of MS peak for the time 
interval of 0.5 min, between minute 1.5 and minute 2, the time when the intensity of 2:1 
Cu
2+:Aβ(1-16) complex increased based on copper binding to 1:1 Cu2+:Aβ(1-16) complex 
(Fig. 5). After minute 6, an increase in the intensity of 3:1 Cu
2+:Aβ(1-16) complex on the 
expense of 2:1 Cu
2+:Aβ(1-16) complex intensity was observed, while the 3:1 Cu2+:Aβ(1-16) 
complex formation for 2-4.5 min interval was dependent on 1:1 Cu
2+:Aβ(1-16) complex. 
Taken together, the sum of the intensities of complexes with one, two, and three copper ions 
increased quickly in the first two minutes and remained almost constant for the next minutes 
of experiments. 
At 1:1 copper: Aβ(1-16) peptide molar ratio, the intensity of free peptide peak 
decreased slowly and continuously over the experimental time (Fig. 6). The 1:1 Cu
2+:Aβ(1-
16) complex formed quickly in the first two minutes from mixing the two solutions, but the 
process continued up to minute 4, when a maximum of intensity was attained. Both intensities 
of 2:1 Cu
2+:Aβ(1-16) and 3:1 Cu2+:Aβ(1-16) complexes increased slowly.  
 Discussion 
Our results revealed the time-dependent formation of peptide-metal ion complexes in 
solution, namely Aβ(1–16): Cu2+ complexes that could be detected by ESI-MS in the gas 
phase. The complex formation was mainly dependent on the metal concentration and less on 
pH; however, it seemed to be faster at higher pH, whereas the lower pH stimulated the 
appearance of complexes containing more than two copper ions.  
In contrast to other studies demonstrating the formation of oligomeric species of Aβ(1–
16) peptide in the presence of Cu
2+ 
ions,
2,11-12
 we noticed no oligomerization in the first 
minutes of copper-peptide interaction during the ESI-MS analysis. Working under different 
experimental conditions (preincubated samples, pH 5.5, higher concentrations of copper ions 
and peptide), copper was found to accelerate the aggregation of Aβ(1-16).12 However, such 
complexes did not appear under the experimental conditions described here, probably due to 
the short time of copper-peptide interaction.  
One can expect to find more copper ions bound to A monomer at pH 7.4 than at pH 
6.6, since higher pH may favor copper binding regardless of peptide sequence.
23
 Nevertheless, 
more copper was found to be bound at lower pH, suggesting that brain pH changes could also 
play a role in various neurodegenerative pathologies.  
These results are in agreement with other findings related to pH-dependent metal 
binding to peptides.
22,24-26 
Our data could be highly important to understand metal binding to 
peptides in vivo. For example, if transient concentrations of metals may appear in the body, 
peptides and proteins do not immediately bind such metals. The binding process takes 
minutes as we showed in this work and depends on the metal and peptide concentrations, as 
well as on pH variations. These findings may explain why short stress conditions followed by 
a period of rest do not damage the cell, while long acting, but low intensity stressors may 
result in neurodegeneration. 
 
Concluding remarks 
Taken together, our results indicate that copper ions
 
specifically bind to A(1-16) peptide in 
solution and that this process is time-dependent. Changing the pH value from 7.4 to 6.6, only 
slightly influences the Cu
2+ 
binding to the peptide. Nevertheless, more copper ions bind to 
A(1-16) at pH 6.6 than at pH 7.4, although the complex formation is faster at pH 7.4. These 
results could be useful to understand the long lasting, pH-dependent interaction of copper ions 
with β-amyloid peptides involved in the pathogenesis of AD.  
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Figure captions 
 
Figure 1. ESI-ion trap mass spectra of A(1-16) peptide (10 µM peptide concentration), 
which show time-dependent formation of complexes with copper ions at pH 7.4 in 5 mM 
ammonium acetate solution.  
 
 
Figure 2. ESI-ion trap mass spectra of A(1-16) peptide (10 µM peptide concentration in 5 
mM ammonium acetate solution, pH 6.6) in the presence of copper ions (1:1 and 1:10 
peptide: copper molar ratios). 
 
 
Figure 3. ESI-ion trap mass spectra of A(1-16) peptide in the presence of highly 
concentrated copper ion solutions, at two pH values (10 µM peptide concentration in 5 mM 
ammonium acetate; pH 7.4 and 6.6, respectively; [Cu
2+
]: [A(1-16)] 1:10). The spectra show 
the formation of Cu
2+
-Aβ(1-16) complexes in which the monomer peptide binds up to 3 or 
even 4 copper ions.  
 
Figure 4. Circular dichroism spectra of Aβ(1-16) and its copper complexes formed in the first 
minutes after mixing the two solutions. 
 
Figure 5. Time dependent copper binding to A(1-16) at pH 6.6 and 1:10 peptide: copper 
molar ratio. 
 
Figure 6. Time dependent copper binding to A(1-16) at pH 7.4 and 1:1 peptide: copper 
molar ratio. 
 
 
